Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN953153 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Lactate Dehydrogenase A (LDHA) (AA 161-190), (Middle Region) antibody
- Antibody type
- Polyclonal
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 161-190, Middle Region
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins.
Detecting rare variants for complex traits using family and unrelated data.
Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy.
Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer.
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.
Zhuang L, Scolyer RA, Murali R, McCarthy SW, Zhang XD, Thompson JF, Hersey P
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010 Jan;23(1):45-53
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010 Jan;23(1):45-53
Detecting rare variants for complex traits using family and unrelated data.
Zhu X, Feng T, Li Y, Lu Q, Elston RC
Genetic epidemiology 2010 Feb;34(2):171-87
Genetic epidemiology 2010 Feb;34(2):171-87
Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy.
Koukourakis MI, Giatromanolaki A, Winter S, Leek R, Sivridis E, Harris AL
Oncology 2009;77(5):285-92
Oncology 2009;77(5):285-92
Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
Zhao YH, Zhou M, Liu H, Ding Y, Khong HT, Yu D, Fodstad O, Tan M
Oncogene 2009 Oct 22;28(42):3689-701
Oncogene 2009 Oct 22;28(42):3689-701
LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer.
Xie H, Valera VA, Merino MJ, Amato AM, Signoretti S, Linehan WM, Sukhatme VP, Seth P
Molecular cancer therapeutics 2009 Mar;8(3):626-35
Molecular cancer therapeutics 2009 Mar;8(3):626-35
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.
Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, Hu Y, Tan Z, Stokes M, Sullivan L, Mitchell J, Wetzel R, Macneill J, Ren JM, Yuan J, Bakalarski CE, Villen J, Kornhauser JM, Smith B, Li D, Zhou X, Gygi SP, Gu TL, Polakiewicz RD, Rush J, Comb MJ
Cell 2007 Dec 14;131(6):1190-203
Cell 2007 Dec 14;131(6):1190-203
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS